Comparison of apomorphine and levodopa infusions in four patients with Parkinson's disease with symptom fluctuations

Acta Neurologica Scandinavica

Volumn 119, Issue 5, 2009, Pages 345-348

  Nyholm, Dag ^a   Constantinescu, R ^b   Holmberg, B ^b   Dizdar, N ^c   Askmark, H ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apomorphine; Carbidopa; Infusion pumps; Levodopa; Parkinson's disease

Indexed keywords

APO GO; APOMORPHINE; BENSERAZIDE PLUS LEVODOPA; CABERGOLINE; CARBIDOPA PLUS LEVODOPA; CLOZAPINE; ENTACAPONE; LEVODOPA; ROPINIROLE; UNCLASSIFIED DRUG;

ADULT; AGED; CASE REPORT; COMPARATIVE STUDY; DYSKINESIA; FEMALE; HUMAN; MALE; MONOTHERAPY; MOTOR PERFORMANCE; NOTE; PARKINSON DISEASE; QUALITY OF LIFE; RATING SCALE; SELF EVALUATION; VIDEORECORDING;

ADMINISTRATION, ORAL; AGED; APOMORPHINE; CROSS-OVER STUDIES; DOPAMINE AGENTS; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFUSION PUMPS; INFUSIONS, SUBCUTANEOUS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 64549121148     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2008.01104.x     Document Type: Note

References (10)

1. Chapuis S, Ouchchane L, Metz O, Gerbaud L, Durif F. Impact of the motor complications of Parkinson's disease on the quality of life. Mov Disord 2005 20 : 224 30.
2. Wolters E. Deep brain stimulation and continuous dopaminergic stimulation in advanced Parkinson's disease. Parkinsonism Relat Disord 2007 13 (Suppl. S18 23.
3. Schapira AH. Treatment options in the modern management of Parkinson disease. Arch Neurol 2007 64 : 1083 8.
4. Nyholm D. Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease. Expert Rev Neurother 2006 6 : 1403 11.
5. Deleu D, Hanssens Y, Northway MG. Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease. Drugs Aging 2004 21 : 687 709.
6. Kleiner-Fisman G, Herzog J, Fisman DN et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006 21 (Suppl. 14 S290 304.
7. Nyholm D, Nilsson Remahl AI, Dizdar N et al. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease. Neurology 2005 64 : 216 23.
8. Manson AJ, Turner K, Lees AJ. Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients. Mov Disord 2002 17 : 1235 41.
9. Isacson D, Bingefors K, Kristiansen IS, Nyholm D. Fluctuating functions related to quality of life in advanced Parkinson disease: effects of duodenal levodopa infusion. Acta Neurol Scand 2008 DOI
10. Nyholm D, Lewander T, Johansson A, Lewitt PA, Lundqvist C, Aquilonius SM. Enteral levodopa/carbidopa infusion in advanced Parkinson disease: long-term exposure. Clin Neuropharmacol 2008 31 : 63 73.